Skip to results
Modify your search
NARROW
1-6 of 6
Authors: George L Bakris
Journal Article
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Nephrology Dialysis Transplantation, Volume 40, Issue 2, February 2025, Pages 308–319, https://doi.org/10.1093/ndt/gfae132
Published: 11 June 2024
Journal Article
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Nephrology Dialysis Transplantation, Volume 38, Issue 2, February 2023, Pages 372–383, https://doi.org/10.1093/ndt/gfac157
Published: 22 April 2022
Journal Article
EDITOR'S CHOICE
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results
Nephrology Dialysis Transplantation, Volume 37, Issue 7, July 2022, Pages 1261–1269, https://doi.org/10.1093/ndt/gfab336
Published: 25 November 2021
Journal Article
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial Get access
Nephrology Dialysis Transplantation, Volume 28, Issue 11, November 2013, Pages 2841–2850, https://doi.org/10.1093/ndt/gft445
Published: 01 November 2013
Journal Article
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented Get access
Nephrology Dialysis Transplantation, Volume 24, Issue 3, March 2009, Pages 695–697, https://doi.org/10.1093/ndt/gfp027
Published: 01 March 2009
Journal Article
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Get access
Nephrology Dialysis Transplantation, Volume 21, Issue 9, September 2006, Pages 2366–2374, https://doi.org/10.1093/ndt/gfl309
Published: 17 June 2006
